• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. A liver-humanized mouse model of carbamoyl phosphate synthetase 1-deficiency.

A liver-humanized mouse model of carbamoyl phosphate synthetase 1-deficiency.

Details
Files
DOI
10.7892/boris.136890
Publisher DOI
10.1002/jimd.12067
PubMed ID
30843237
Abstract
A liver-humanized mouse model for CPS1-deficiency was generated by the high-level repopulation of the mouse liver with CPS1-deficient human hepatocytes. When compared with mice that are highly repopulated with CPS1-proficient human hepatocytes, mice that are repopulated with CPS1-deficient human hepatocytes exhibited characteristic symptoms of human CPS1 deficiency including an 80% reduction in CPS1 metabolic activity, delayed clearance of an ammonium chloride infusion, elevated glutamine and glutamate levels, and impaired metabolism of [15 N]ammonium chloride into urea, with no other obvious phenotypic differences. Because most metabolic liver diseases result from mutations that alter critical pathways in hepatocytes, a model that incorporates actual disease-affected, mutant human hepatocytes is useful for the investigation of the molecular, biochemical, and phenotypic differences induced by that mutation. The model is also expected to be useful for investigations of modified RNA, gene, and cellular and small molecule therapies for CPS1-deficiency. Liver-humanized models for this and other monogenic liver diseases afford the ability to assess the therapy on actual disease-affected human hepatocytes, in vivo, for long periods of time and will provide data that are highly relevant for investigations of the safety and efficacy of gene-editing technologies directed to human hepatocytes and the translation of gene-editing technology to the clinic.
Date Issued
2019-11
Publication Type
Article
Subject(s)
600 Technology > 610 Medicine & health
Subjects
CPS1-deficiency liver-humanized mice urea cycle defects
Language(s)
en
Author(s)
Srinivasan, Raghuraman C
Zabulica, Mihaela
Hammarstedt, Christina
Wu, Tingting
Gramignoli, Roberto
Kannisto, Kristina
Ellis, Ewa
Karadagi, Ahmad
Fingerhut, Ralph
Allegri, Gabriella
Rüfenacht, Véronique
Thöny, Beat
Häberle, Johannes
Nuoffer, Jean-Marc  orcid-logo
Universitätsinstitut für Klinische Chemie (UKC)  
Strom, Stephen C
Additional Credits
Universitätsinstitut für Klinische Chemie (UKC)  
Journal
Journal of inherited metabolic diseases
Publisher
Wiley
ISSN
0141-8955
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: 24f0a9 [ 4.09. 8:55]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • BORIS Portal & Open Science
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo
Repository logo COAR Notify